Bacillus subtilis is a safe, efficient, multi-functional, and promising microbial strain, which is widely used in animal husbandry and the planting industry. Lifeasible provides selection and development services for Bacillus subtilis in response to the problem of single product variety and uneven product quality in the market. We have extensive experience in the selection and breeding of superior Bacillus subtilis strain resources, genetic metabolism, and commercial production. We can find mutagenesis sources with high mutation rates and a wide mutation spectrum for you to obtain strains with stable genetic traits and high activity. And through genomics technology to make it better applied to feed and fertilizer formulation improvement, production processing, and other fields.
To meet the market demand for high-quality Bacillus subtilis strains, we can perform the selection of Bacillus subtilis strains for you. This includes mutagenesis breeding service for Bacillus subtilis with high chitinase production and selection and breeding service for Bacillus subtilis with high bacteriocin production.
The selection of strains and the control of fermentation conditions are two complementary aspects. To maximize the production advantages of the superior strains obtained from the breeding work, we have also improved the fermentation process and the fermentation medium to compose a system that is suitable for it.
The isolation and purification of Bacillus subtilis antimicrobial active substances and their development have become a hot research topic for the improvement of feed fertilizer and additive processing. To meet the needs of researchers and customers in the production field for a more in-depth discovery of new active compounds, we can provide you with services for the extraction, isolation, purification, identification, and development of Bacillus subtilis active ingredients (antimicrobial peptides or other antimicrobial components).
In addition to processing strains isolated in their natural environment, we can also develop active ingredients for mutagenic strains in combination with our existing technology platform to meet your diverse analytical and production needs.
Bacillus subtilis is a non-pathogenic and safe microorganism that has great potential for applications in the field of feed and fertilizer, such as in the fermentation process of feed and fertilizer production. To achieve maximum productivity in production such as feed and fertilizer fermentation, we can improve and streamline the genome of Bacillus subtilis using gene knockout, knock-in, and point mutation to obtain the optimal strain.
We offer optimization strategies designed to maximize the production of target products while maintaining the growth of the strain itself by knocking out non-essential and redundant genes without significantly affecting the growth state of the strain. We can provide our customers with easy-to-use Bacillus subtilis that are free of resistance markers, with high transformation efficiency and high secretion capacity.
Our advantages
- We have used various techniques to deeply explore the diverse strain resources of Bacillus subtilis and established a screening model and its technical system.
- We can screen out highly active and productive functional bacteria and have built a corresponding strain library.
- We have realized the integration and optimization of functional properties of strains oriented to industrial applications using genomics technology.
- We have key technologies for fermentation culture, isolation, preparation, and activity maintenance of Bacillus subtilis, and have obtained ferments with high viable counts and vigor.
Lifeasible provides selection and development services for Bacillus subtilis to obtain strains with stable genetic traits and high yields. We also combine our molecular biology technology and active ingredient development system to meet the diverse analytical and production needs of our customers. Please feel free to contact our staff for more information.
For research use only, not intended for any clinical use.
